Bioxyne Ltd

BXN

Company Profile

  • Business description

    Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus fermentum PCC. Some of its products include Breathe Life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange, and others. The company operates in segments namely, wholesale sales, Plant-based, Manufacturing sales, and direct sales. The majority of the revenue is generated from plants based segment.

  • Contact

    50 Clarence Street
    Suite 506, Level 5
    SydneyNSW2000
    AUS

    T: +61 290787669

    https://www.bioxyne.com

  • Sector

    Consumer Defensive

    Stock type

    Defensive

  • Industry

    Packaged Foods

    Fiscal Year End

    30 June 2026

    Employees

    16

Stocks News & Analysis

stocks

Wildly overvalued ASX stock is skating on thin ice

This company dominates its industry and could be flirting with regulatory intervention.
stocks

Uber flexes its network effect and delivers strong result

Uber’s business is humming along but autonomous vehicles add uncertainty to the longer term outlook.
stocks

Ask the analyst: Are Qantas shares a value trap?

Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,102.009.10-0.10%
CAC 407,635.0313.990.18%
DAX 4023,924.3678.290.33%
Dow JONES (US)44,193.1281.380.18%
FTSE 1009,164.3121.580.24%
HKSE25,096.96186.330.75%
NASDAQ21,169.42252.871.21%
Nikkei 22541,059.15264.290.65%
NZX 50 Index12,887.106.940.05%
S&P 5006,345.0645.870.73%
S&P/ASX 2008,831.4012.30-0.14%
SSE Composite Index3,640.376.380.18%

Market Movers